Literature DB >> 19899988

Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population.

Xue-Ting Pei1, Xiao-Xin Li, Yong-Zhen Bao, Wen-Zhen Yu, Zheng Yan, Hui-Jun Qi, Tong Qian, Hong-Xiang Xiao.   

Abstract

PURPOSE: The purpose of this study was to determine whether the genetic polymorphisms of complement factor 3 (C3) are associated with neovascular age-related macular degeneration (AMD) in the Chinese population.
METHODS: A total of 123 unrelated Chinese Han patients with neovascular AMD and 130 control subjects were recruited. Their six single-nucleotide polymorphisms (SNPs) in the C3 gene, one in the complement factor H (CFH) gene and two in the complement factor B (CFB) gene were characterized. Their genotypes, allele frequencies, and odds ratios were analyzed.
RESULTS: The G allele of the C3 IVS2 rs2250656, but not other tested C3 SNPs of rs2230205, rs10411506, rs2230199, rs339392, and rs163913, was significantly associated with a reduced risk for AMD in the Chinese population (OR 0.605, 95% CI 0.39-0.93, p = 0.023), even after adjusting for age, gender, smoking status, CFH rs1061170, CFB rs4151667, and CFB rs641153 allele status (OR 0.58, 95% CI 0.35-0.96, p = 0.033). However, the C3 haplotype of A-A-C-A-T-T was identified as a statistically significant risk factor for neovascular AMD (OR 1.41, 95% CI 1.02-1.94). Furthermore, the C allele of the CFH rs1061170, but not the CFB rs4151667 and rs641153, was significnatly associated with increased risk for AMD (OR 3.09, 95% CI 1.55-6.15, p < 0.001).
CONCLUSION: The G allele of C3 IVS2 rs2250656 may be a significantly protective factor for neovascular AMD in the Chinese population. This, together with low MAF of C3 R102G, may be partially responsible for the low prevalence of AMD in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19899988     DOI: 10.1080/02713680903003484

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  18 in total

Review 1.  Genetics of age-related macular degeneration: current concepts, future directions.

Authors:  Margaret M Deangelis; Alexandra C Silveira; Elizabeth A Carr; Ivana K Kim
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

2.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

3.  Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population.

Authors:  Lin Wu; Qiushan Tao; Wen Chen; Zhi Wang; Yanping Song; Shuangyan Sheng; Pengcheng Li; Jingjing Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

4.  Complement factor B polymorphism (rs641153) and susceptibility to age-related macular degeneration: evidence from published studies.

Authors:  Xin Wang; Ying Zhang; Mao-Nian Zhang
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

5.  Association between complementary factor H Y402H polymorphisms and age-related macular degeneration in Chinese: Systematic review and meta-analysis.

Authors:  Yan-Long Quan; Ai-Yi Zhou; Zhao-Hui Feng
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

6.  The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

Authors:  Peter James Francis
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

Review 7.  Complement Mediators in Development to Treat Age-Related Macular Degeneration.

Authors:  Marcella Nebbioso; Federica Franzone; Alessandro Lambiase; Samanta Taurone; Marco Artico; Magda Gharbiya; Antonio Greco; Antonella Polimeni
Journal:  Drugs Aging       Date:  2022-01-20       Impact factor: 3.923

8.  A common complement C3 variant is associated with protection against wet age-related macular degeneration in a Japanese population.

Authors:  Suiho Yanagisawa; Naoshi Kondo; Akiko Miki; Wataru Matsumiya; Sentaro Kusuhara; Yasutomo Tsukahara; Shigeru Honda; Akira Negi
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

9.  Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients.

Authors:  Won Kyung Song; Kyung-Mi Park; Hyun-Ju Kim; Jae Ho Lee; Jinjung Choi; So Young Chong; Sung Han Shim; Lucian V Del Priore; Robert Lanza
Journal:  Stem Cell Reports       Date:  2015-04-30       Impact factor: 7.765

10.  Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome.

Authors:  Dengfeng Xu; Shengping Hou; Jun Zhang; Yanni Jiang; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.